Ubs Group Ag Alkermes Plc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Alkermes Plc. stock. As of the latest transaction made, Ubs Group Ag holds 507,419 shares of ALKS stock, worth $14.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

507,419

Previous 466,786 8.7%

Holding current value

$14.3 Million

Previous $11.2 Million 26.25%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $934,965 - $1.16 Million	40,633 Added 8.7%	507,419 $14.2 Million
Q2 2024 Aug 13, 2024	BUY	$23.21 - $27.24 $1.26 Million - $1.47 Million	54,121 Added 13.11%	466,786 $11.2 Million
Q1 2024 May 13, 2024	BUY	$26.4 - $32.56 $3.72 Million - $4.59 Million	140,908 Added 51.85%	412,665 $11.2 Million
Q4 2023 Feb 09, 2024	BUY	$23.37 - $28.68 $3.22 Million - $3.95 Million	137,691 Added 102.7%	271,757 $7.54 Million
Q3 2023 Nov 09, 2023	BUY	$27.17 - $31.97 $3.06 Million - $3.61 Million	112,803 Added 530.51%	134,066 $3.76 Million
Q2 2023 Aug 11, 2023	SELL	$28.34 - $33.63 $36,671 - $43,517	-1,294 Reduced 5.74%	21,263 $665,000
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $66,894 - $76,699	2,643 Added 13.27%	22,557 $635,000
Q4 2022 Feb 08, 2023	BUY	$21.94 - $26.24 $329 - $393	15 Added 0.08%	19,914 $520,000
Q3 2022 Nov 10, 2022	SELL	$22.0 - $31.87 $182,006 - $263,660	-8,273 Reduced 29.37%	19,899 $444,000
Q2 2022 Aug 10, 2022	SELL	$26.4 - $30.54 $229,442 - $265,423	-8,691 Reduced 23.58%	28,172 $839,000
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $153,507 - $186,245	6,654 Added 22.03%	36,863 $970,000
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $201,903 - $301,680	9,404 Added 45.2%	30,209 $702,000
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $6.11 Million - $8.4 Million	-261,401 Reduced 92.63%	20,805 $642,000
Q2 2021 Aug 13, 2021	SELL	$18.78 - $25.15 $28.4 Million - $38.1 Million	-1,514,727 Reduced 84.3%	282,206 $6.92 Million
Q1 2021 May 12, 2021	SELL	$18.21 - $23.2 $20.5 Million - $26.1 Million	-1,126,379 Reduced 38.53%	1,796,933 $33.6 Million
Q4 2020 Feb 11, 2021	BUY	$15.39 - $22.1 $26.2 Million - $37.7 Million	1,705,003 Added 139.95%	2,923,312 $58.3 Million
Q3 2020 Nov 12, 2020	SELL	$16.16 - $20.66 $12 Million - $15.3 Million	-742,577 Reduced 37.87%	1,218,309 $20.2 Million
Q2 2020 Jul 31, 2020	BUY	$13.31 - $19.41 $21 Million - $30.7 Million	1,579,622 Added 414.31%	1,960,886 $38.1 Million
Q1 2020 May 01, 2020	BUY	$13.06 - $21.24 $4.24 Million - $6.89 Million	324,621 Added 573.1%	381,264 $5.5 Million
Q4 2019 Feb 14, 2020	SELL	$17.29 - $21.74 $5.69 Million - $7.15 Million	-328,832 Reduced 85.31%	56,643 $1.16 Million
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $4.03 Million - $5.02 Million	206,563 Added 115.46%	385,475 $7.52 Million
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $1.84 Million - $3.21 Million	85,931 Added 92.42%	178,912 $4.03 Million
Q1 2019 May 14, 2019	SELL	$28.4 - $36.49 $1.88 Million - $2.42 Million	-66,206 Reduced 41.59%	92,981 $3.39 Million
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $505,518 - $807,128	18,093 Added 12.82%	159,187 $4.7 Million
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $969,670 - $1.16 Million	25,121 Added 21.66%	141,094 $5.99 Million
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $2.68 Million - $3.39 Million	-65,952 Reduced 36.25%	115,973 $4.77 Million
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $3.76 Million - $4.72 Million	70,156 Added 62.77%	181,925 $10.5 Million
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $232,297 - $269,804	4,871 Added 4.56%	111,769 $6.12 Million
Q3 2017 Nov 14, 2017	SELL	$49.16 - $54.45 $2.1 Million - $2.33 Million	-42,748 Reduced 28.57%	106,898 $5.44 Million
Q2 2017 Aug 14, 2017	BUY	N/A	53,201 Added 55.16%	149,646 $8.68 Million
Q1 2017 Nov 14, 2017	BUY	N/A	96,445	96,445 $5.64 Million

Others Institutions Holding ALKS

# of Institutions

360

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.63B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account